Pro-resolution mediator lipoxin A4 and Its receptor in upper airway inflammation

Annals of Otology, Rhinology and Laryngology

Volumn 122, Issue 11, 2013, Pages 683-689

  Shimizu, Shino ^a   Ogawa, Takao ^a   Seno, Satoshi ^a   Kouzaki, Hideaki ^a   Shimizu, Takeshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Allergic rhinitis; Chronic rhinosinusitis; Formyl peptide receptor like 1; Lipoxin A4; Lipoxygenase; Nasal polyp

Indexed keywords

FORMYLPEPTIDE RECEPTOR LIKE 1; INTERLEUKIN 8; LIPOXIN A; LIPOXIN RECEPTOR; LIPOXYGENASE; MESSENGER RNA; PEPTIDOLEUKOTRIENE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MEDIATOR RELEASE; NOSE POLYP; NOSE SECRETION; NOSE SURGERY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TISSUE DISTRIBUTION; TURBINATE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84889239797     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941312201104     Document Type: Article

References (20)

1. Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007;30:980-92.
2. Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol 2009;158:947-59.
3. Karp CL, Flick LM, Park KW, et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 2004;5:388-92.
4. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E; Severe Asthma Research Program, National Heart, Lung, and Blood Institute. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005;172:824-30.
5. Planagumà A, Kazani S, Marigowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008;178:574-82.
6. Levy BD, Lukacs NW, Berlin AA, et al. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J 2007;21:3877-84.
7. Thomas M, Yawn BP, Price D, Lund V, Mullol J, Fokkens W; European Position Paper on Rhinosinusitis and Nasal Polyps Group. EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. Prim Care Respir J 2008;17:79-89.
8. Global Initiative for Asthma (GINA), National Heart, Lung, and Blood Institute, eds. Global strategy for asthma management and prevention. Bethesda, Md: NHLBI, 2006.
9. Committee of the Practical Guideline for the Management of Allergic Rhinitis, eds. Practical guideline for the management of allergic rhinitis in Japan. Tokyo, Japan: Life Science Publishing, 2009.
10. Pérez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol 2005;115:1189-96.
11. Rostkowska-Nadolska B, Kapral M, Fraczek M, Kowalczyk M, Gawron W, Mazurek U. A microarray study of gene expression profiles in nasal polyps. Auris Nasus Larynx 2011;38:58-64.
12. Claesson HE. On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. Prostaglandins Other Lipid Mediat 2009;89:120-5.
13. Serhan CN, Jain A, Marleau S, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856-65.
14. Hsi LC, Wilson LC, Eling TE. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on mapk signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma. J Biol Chem 2002;277:40549-56.
15. Mangino MJ, Brounts L, Harms B, Heise C. Lipoxin biosynthesis in inflammatory bowel disease. Prostaglandins Other Lipid Mediat 2006;79:84-92.
16. Bonnans C, Gras D, Chavis C, et al. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells. Biomed Pharmacother 2007;61:261-7.
17. Romano M, Recchia I, Recchiuti A. Lipoxin receptors. ScientificWorldJournal 2007;7:1393-412.
18. József L, Zouki C, Petasis NA, Serhan CN, Filep JG. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci U S A 2002;99:13266-71.
19. Kure I, Nishiumi S, Nishitani Y, et al. Lipoxin A4 reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-κB activation. J Pharmacol Exp Ther 2010;332:541-8.
20. Wu S-H, Liao P-Y, Dong L, Chen Z-Q. Signal pathway involved in inhibition by lipoxin A4 of production of interleukins induced in endothelial cells by lipopolysaccharide. Inflamm Res 2008;57:430-7.